Active Ingredient History
Epidermal growth factor (EGF) is a protein that stimulates cell growth and differentiation by binding to its receptor, EGFR. Human EGF is 6-kDa and has 53 amino acid residues and three intramolecular disulfide bonds. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Anesthesia (Phase 1)
Burns (Phase 2/Phase 3)
Carcinoma, Mucoepidermoid (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2/Phase 3)
Colorectal Neoplasms (Phase 2/Phase 3)
Diabetes Mellitus (Phase 3)
Diabetic Foot (Phase 3)
Dry Eye Syndromes (Phase 1)
Epidermal Growth Factor (Phase 3)
Glaucoma (Phase 1)
Graft vs Host Disease (Phase 1)
Mesenchymal Stem Cell Transplantation (Phase 1)
Ocular Hypertension (Phase 1)
Pancreatic Neoplasms (Phase 2/Phase 3)
Periodontitis (Phase 1)
Psoriasis (Phase 1)
Squamous Cell Carcinoma of Head and Neck (Phase 3)
Stomatitis (Phase 3)
Temporomandibular Joint Disorders (Phase 4)
Tongue Neoplasms (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue